Skip to content

Expanded Access Use of Itacitinib to Treat a Single Patient With Aplastic Anemia

Expanded Access Use of Itacitinib to Treat a Single Patient With Aplastic Anemia

Status
NO_LONGER_AVAILABLE
Phases
Unknown
Study type
Expanded Access
Source
ClinicalTrials.gov
Registry ID
NCT03906318
Enrollment
Unknown
Registered
2019-04-08
Start date
Unknown
Completion date
Unknown
Last updated
2022-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aplastic Anemia

Brief summary

Expanded Access Use of Itacitinib to Treat a Single Patient With Aplastic Anemia

Interventions

DRUGIticitinib

Sponsors

Incyte Corporation
Lead SponsorINDUSTRY

Eligibility

Inclusion criteria

\-

Exclusion criteria

\-

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026